Immix Biopharma’s NXC-201 NEXICART-2 Interim Clinical Trial Results Selected for Oral Presentation at ASH 2026
– Data will be presented on Monday, December 14, 2026 at 11:15 AM CDT –
– Data will be presented on Monday, December 14, 2026 at 11:15 AM CDT –